The purpose of this study is to determine whether daily consumption of soluble fibre, oat beta glucan (4g), for six weeks will have any impact on overweight/obese individuals in terms of risk factors used to define metabolic disease.
The purpose of this study is to determine whether daily consumption oat beta glucan (4g) for six weeks will have any impact on overweight/obese individuals in terms of risk factors used to define metabolic disease. Oat beta-glucan has been incorporated into a novel oatcake product manufactured by Nairn's Oatcakes Ltd. Consumption of the oatcake products will deliver enough oat-beta glucan to the diet to meet European Food Safety Authority health claims for lowering blood cholesterol and reducing post-prandial glycaemic responses.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
90
5 oatcakes enriched with oat beta-glucan will be consumed daily for six weeks
6.5 wheat based control snacks without beta-glucan will be consumed daily for six weeks
Queen Margaret University, Edinburgh
Musselburgh, East Lothain, United Kingdom
Waist Circumference
Time frame: 6 weeks
Blood Pressure
Time frame: 6 Weeks
Fasting Serum Triglycerides
Time frame: 6 weeks
Oral Glucose Tolerance Test
Time frame: 6 weeks
Fasting Serum HDL Cholesterol
Time frame: 6 Weeks
Fasting Serum total Cholesterol
Time frame: 6 weeks
Interleukin-6
Time frame: 6 weeks
Energy Intakes (kilocalories) and Macronutrient intakes (grams) from food diaries
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.